Compare FLOC & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FLOC | CBLL |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | United States | United States |
| Employees | 1281 | 280 |
| Industry | Metal Fabrications | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 692.3M | 750.1M |
| IPO Year | N/A | N/A |
| Metric | FLOC | CBLL |
|---|---|---|
| Price | $22.83 | $19.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $29.60 | $24.67 |
| AVG Volume (30 Days) | ★ 331.6K | 299.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.40% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.85 | $29.57 |
| Revenue Next Year | $8.11 | $28.44 |
| P/E Ratio | $16.57 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.03 | $10.01 |
| 52 Week High | $26.51 | $24.33 |
| Indicator | FLOC | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 53.52 | 49.30 |
| Support Level | $15.12 | $18.78 |
| Resistance Level | $24.17 | $20.09 |
| Average True Range (ATR) | 1.10 | 0.88 |
| MACD | -0.15 | 0.11 |
| Stochastic Oscillator | 37.62 | 74.46 |
Flowco Holdings Inc is a provider of production optimization, artificial lift, emissions management, and monetization solutions for the oil and natural gas industry. Its technologies include high-pressure gas lift (HPGL), conventional gas lift, plunger lift, and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions, which includes rental services, and Natural Gas Technologies, which include service, gas compression parts, and equipment sales. Production Solutions: relates to rentals, sales, and services related to high-pressure gas lift, conventional gas lift, and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue. It generates maximum revenue from the United States.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.